Application 206582
- Type
- ANDA
- Sponsor
- ACTAVIS ELIZABETH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OMEPRAZOLE MAGNESIUM | OMEPRAZOLE MAGNESIUM | TABLET, DELAYED RELEASE;ORAL | EQ 20MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206582-001 | OMEPRAZOLE MAGNESIUM | OMEPRAZOLE MAGNESIUM | EQ 20MG BASE | TABLET, DELAYED RELEASE / ORAL | RS | 2020-06-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A206582-001 | OMEPRAZOLE MAGNESIUM | EQ 20MG BASE | TABLET, DELAYED RELEASE / ORAL | 2020-06-01 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prilosec OTC | OMEPRAZOLE MAGNESIUM | The Procter & Gamble Manufacturing Company | 37291cab-e350-d8e3-e063-6294a90a9cb1 | 2026-10-06 | Warnings | 206582 ANDA206582 |
| Prilosec OTC | OMEPRAZOLE MAGNESIUM | The Procter & Gamble Manufacturing Company | c7229a69-07e7-4690-8fc0-1f0f093bf230 | 2026-10-06 | Warnings | 206582 ANDA206582 |
| Omeprazole Delayed release | OMEPRAZOLE | H2-Pharma, LLC | e57531a7-2047-4531-acac-30bc8e3924fc | 2026-09-03 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | P & L Development, LLC | 883e428a-e157-4bbf-8657-e7a93dc99e8c | 2026-07-14 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | WALMART INC. (see also Equate) | d3c1ba08-680d-4e39-875c-1f1d42ae787c | 2026-07-13 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | PLD Acquisitions LLC DBA Avma Pharma Solutions | d9c8a242-bdba-4f92-8629-692b47ebba21 | 2026-06-26 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | PLD Acquisitions LLC DBA Avma Pharma Solutions | 71add294-ff24-4bbf-9067-7c56ed7c9f1a | 2026-06-26 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | PLD Acquisitions LLC DBA Avma Pharma Solutions | e67bf2c6-0618-48e0-aa08-705501d86431 | 2026-06-26 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | PLD Acquisitions LLC DBA Avma Pharma Solutions | 6a1aeb95-5760-4363-816a-fa8305979c50 | 2026-06-26 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | P & L Development, LLC | 911a08c4-ba73-4600-a5f2-7f26ba8c8604 | 2026-06-25 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | Walgreens | b9683a94-fd44-4364-be0e-477ca1a29aba | 2026-03-27 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | WinCo Foods, LLC | 2782b98b-50e4-4a4e-8626-d34ebfd71bfb | 2026-01-14 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | Family Dollar (FAMILY WELLNESS) | f2195d73-1fd5-4de2-aa5c-18741d11f4fc | 2025-10-30 | Warnings | 206582 ANDA206582 |
| Omeprazole | OMEPRAZOLE | P & L Development, LLC | 44a92926-1941-4fe8-9b2a-31a45289456f | 2025-06-02 | Warnings | 206582 ANDA206582 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 59726-297 | Omeprazole | Omeprazole magnesium | P & L Development, LLC | ANDA | Current |
| 59726-297 | Omeprazole | Omeprazole magnesium | P & L Development, LLC | ANDA | Current |
| 59726-737 | Omeprazole | Omeprazole magnesium | P & L Development, LLC | ANDA | Current |
| 59726-737 | Omeprazole | Omeprazole magnesium | P & L Development, LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 50730 | ORIG | 2017-12-18 |